相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer
C. Wilson et al.
ONCOGENE (2017)
Role of steroid receptor and coregulator mutations in hormone-dependent cancers
Anna C. Groner et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
KDM4B/JMJD2B is a p53 target gene that modulates the amplitude of p53 response after DNA damage
Laura Castellini et al.
NUCLEIC ACIDS RESEARCH (2017)
Design of KDM4 Inhibitors with Antiproliferative Effects in Cancer Models
Young K. Chen et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
KDM4 Inhibition Targets Breast Cancer Stem-like Cells
Eric Metzger et al.
CANCER RESEARCH (2017)
Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox
Jun Yang et al.
CANCER RESEARCH (2017)
Strong KDM4B and KDM4D Expression Associates with Radioresistance and Aggressive Phenotype in Classical Hodgkin Lymphoma
Hamid Bur et al.
ANTICANCER RESEARCH (2016)
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer
Xiaoyong Fu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Selective Estrogen Receptor Modulators Suppress Hif1α Protein Accumulation in Mouse Osteoclasts
Mayu Morita et al.
PLOS ONE (2016)
The Role of Histone Demethylase KDM4B in Myc Signaling in Neuroblastoma
Jun Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Estrogen receptor-α directly regulates the hypoxia-inducible factor 1 pathway associated with antiestrogen response in breast cancer
Jun Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1
Mei-Ting Qiu et al.
ONCOTARGET (2015)
The Role of Histone Demethylase KDM4B in Myc Signaling in Neuroblastoma
Jun Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Mechanisms of Hypoxia-Mediated Immune Escape in Cancer
Ivraym B. Barsoum et al.
CANCER RESEARCH (2014)
HIF-1 Signaling in Drug Resistance to Chemotherapy
N. A. Warfel et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Stimulation of β-catenin and colon cancer cell growth by the KDM4B histone demethylase
William L. Berry et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
KDM4B as a Target for Prostate Cancer: Structural Analysis and Selective Inhibition by a Novel Inhibitor
Chia-Han Chu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Distinct and Combinatorial Functions of Jmjd2b/Kdm4b and Jmjd2c/Kdm4c in Mouse Embryonic Stem Cell Identity
Partha Pratim Das et al.
MOLECULAR CELL (2014)
JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells
Z. S. Walters et al.
ONCOGENE (2014)
p53 promotes repair of heterochromatin DNA by regulating JMJD2b and SUV39H1 expression
H. Zheng et al.
ONCOGENE (2014)
The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes
Robert Huether et al.
NATURE COMMUNICATIONS (2014)
Amplification of Distant Estrogen Response Elements Deregulates Target Genes Associated with Tamoxifen Resistance in Breast Cancer
Pei-Yin Hsu et al.
CANCER CELL (2013)
KDM4/JMJD2 Histone Demethylases: Epigenetic Regulators in Cancer Cells
William L. Berry et al.
CANCER RESEARCH (2013)
JMJD2B Promotes Epithelial-Mesenchymal Transition by Cooperating with β-Catenin and Enhances Gastric Cancer Metastasis
Li Zhao et al.
CLINICAL CANCER RESEARCH (2013)
Kdm4b Histone Demethylase Is a DNA Damage Response Protein and Confers a Survival Advantage following γ-Irradiation
Leah C. Young et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Gregg L. Semenza
JOURNAL OF CLINICAL INVESTIGATION (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs
Jiekai Chen et al.
NATURE GENETICS (2013)
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Weiyi Toy et al.
NATURE GENETICS (2013)
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
Dan R. Robinson et al.
NATURE GENETICS (2013)
Histone lysine demethylases as targets for anticancer therapy
Jonas W. Hojfeldt et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover
Kelly Coffey et al.
NUCLEIC ACIDS RESEARCH (2013)
Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
Jueng Soo You et al.
CANCER CELL (2012)
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
Peppi Koivunen et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Histone methylation: a dynamic mark in health, disease and inheritance
Eric L. Greer et al.
NATURE REVIEWS GENETICS (2012)
Molecular mechanisms and potential functions of histone demethylases
Susanne Marije Kooistra et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
HIF1 alpha and HIF2 alpha: sibling rivalry in hypoxic tumour growth and progression
Brian Keith et al.
NATURE REVIEWS CANCER (2012)
Microarray Comparative Genomic Hybridization Detection of Copy Number Changes in Desmoplastic Melanoma and Malignant Peripheral Nerve Sheath Tumor
Jennifer G. Pryor et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2011)
The Histone Demethylase JMJD2B Plays an Essential Role in Human Carcinogenesis through Positive Regulation of Cyclin-Dependent Kinase 6
Gouji Toyokawa et al.
CANCER PREVENTION RESEARCH (2011)
FOXA1 is a key determinant of estrogen receptor function and endocrine response
Antoni Hurtado et al.
NATURE GENETICS (2011)
Cancer epigenetics reaches mainstream oncology
Manuel Rodriguez-Paredes et al.
NATURE MEDICINE (2011)
Histone Demethylase JMJD2B Functions as a Co-Factor of Estrogen Receptor in Breast Cancer Proliferation and Mammary Gland Development
Masahito Kawazu et al.
PLOS ONE (2011)
Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis
Lei Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Histone Demethylase JMJD2B Is Regulated by Estrogen Receptor α and Hypoxia, and Is a Key Mediator of Estrogen Induced Growth
Jun Yang et al.
CANCER RESEARCH (2010)
Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia
Alice Y. S. Low et al.
EXPERIMENTAL CELL RESEARCH (2010)
Epigenetic modifications and human disease
Anna Portela et al.
NATURE BIOTECHNOLOGY (2010)
Covalent histone modifications - miswritten, misinterpreted and mis-erased in human cancers
Ping Chi et al.
NATURE REVIEWS CANCER (2010)
Role of Hypoxia-Inducible Factors in Epigenetic Regulation via Histone Demethylases
Jun Yang et al.
HYPOXIA AND CONSEQUENCES FROM MOLECULE TO MALADY (2009)
Oncogenic KRAS and BRAF Differentially Regulate Hypoxia-inducible Factor-1α and-2α in Colon Cancer
Hirotoshi Kikuchi et al.
CANCER RESEARCH (2009)
Phosphorylated ERα, HIF-1α, and MAPK Signaling As Predictors of Primary Endocrine Treatment Response and Resistance in Patients With Breast Cancer
Daniele Generali et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Small-Molecule Activation of p53 Blocks Hypoxia-Inducible Factor 1α and Vascular Endothelial Growth Factor Expression In Vivo and Leads to Tumor Cell Apoptosis in Normoxia and Hypoxia
Jun Yang et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma
Paul A. Northcott et al.
NATURE GENETICS (2009)
mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome
David B. Shackelford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis
Xiaobo Xia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Biological determinants of endocrine resistance in breast cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2009)
Hypoxia upregulates the histone demethylase JMJDIA via HIF-1
Sven Wellmann et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1α
Patrick J. Pollard et al.
BIOCHEMICAL JOURNAL (2008)
Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease
Paul A. C. Cloos et al.
GENES & DEVELOPMENT (2008)
The Histone Demethylases JMJD1A and JMJD2B Are Transcriptional Targets of Hypoxia-inducible Factor HIF
Sophie Beyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
HYPOXIA AND METABOLISM SERIES - TIMELINE The impact of O2 availability on human cancer
Jessica A. Bertout et al.
NATURE REVIEWS CANCER (2008)
Histone lysine demethylases: emerging roles in development, physiology and disease
Yang Shi
NATURE REVIEWS GENETICS (2007)
Hypoxia and estrogen co-operate to regulate gene expression in T-47D human breast cancer cells
Ramzi Seifeddine et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Estrogen-induced activation of hypoxia-inducible factor-1α, vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway
Armina A. Kazi et al.
ENDOCRINOLOGY (2007)
Dynamic regulation of histone lysine methylation by demethylases
Yang Shi et al.
MOLECULAR CELL (2007)
Lysyl oxidase mediates hypoxic control of metastasis
Janine T. Erler et al.
CANCER RESEARCH (2006)
PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR
Rosa Bernardi et al.
NATURE (2006)
Mechanisms of tumor regression and resistance to estrogen deprivation and fulvestrant in a model of estrogen receptor-positive, HER-2/neu-positive breast cancer
Suleiman Massarweh et al.
CANCER RESEARCH (2006)
Hypoxia-inducible factor-1α-expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer
Daniele Generali et al.
CLINICAL CANCER RESEARCH (2006)
Estrogen receptor target gene: An evolving concept
Jason S. Carroll et al.
MOLECULAR ENDOCRINOLOGY (2006)
The diverse functions of histone lysine methylation
C Martin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations
PJ Pollard et al.
HUMAN MOLECULAR GENETICS (2005)
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability
JS Isaacs et al.
CANCER CELL (2005)
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase
MA Selak et al.
CANCER CELL (2005)
JunD reduces tumor angiogenesis by protecting cells from oxidative stress
D Gerald et al.
CELL (2004)
Histone demethylation mediated by the nuclear arnine oxidase homolog LSD1
YJ Shi et al.
CELL (2004)
17-β estradiol attenuates hypoxic induction of HIF-1α and erythropoietin in Hep3B cells
H Mukundan et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2004)
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
PK Majumder et al.
NATURE MEDICINE (2004)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer - Results of the ATAC (arimidex, tamoxifen alone or in comhination) trial efficacy and safety update analyses
CANCER (2003)
The basic helix-loop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription
S Brunnberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis:: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
E Laughner et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Low pO2 and β-estradiol induce VEGF in MCF-7 and MCF-7-5C cells:: Relationship to in vivo hypoxia
A Maity et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
Levels of hypoxia-inducible factor-1α during breast carcinogenesis
R Bos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Vascular endothelial growth factor is modulated in vascular muscle cells by estradiol, tamoxifen, and hypoxia
P Bausero et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2000)
Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors α and β
MD Mueller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
